Charles River Laboratories International Inc
(NYSE:CRL)
$
219.4
-0.30 (-0.14%)
Market Cap: 10.57 Bil
Enterprise Value: 13.48 Bil
PE Ratio: 0
PB Ratio: 3.59
GF Score: 70/100 Charles River Laboratories International Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
Nov 12, 2019 / 05:20PM GMT
Release Date Price:
$135.12
(+2.36%)
Erin Elizabeth Wilson Wright;dit Suisse AG
CrÃ;Research Division - Director & Senior Equity Research Analyst
© -
Good afternoon, or good morning, everybody. My name is Erin Wright. I cover life sciences tools and diagnostics at Crédit Suisse. We're happy to have Charles River Laboratories with us today. We have Birgit Girshick. And let me see if I get everything that you do on here, but you're EVP of Discovery and Safety Assessment, Biologics Testing Solutions and Avian Vaccine Services. Hopefully, I got it all there.
Birgit Girshick
Charles River Laboratories International, Inc. - EVP of Discovery & Safety Assessment, Biologics Testing Solutions and Avian Vaccine Services
That is correct.
Questions & Answers
Erin Elizabeth Wilson Wright;dit Suisse AG
CrÃ;Research Division - Director & Senior Equity Research Analyst
© -
So we're happy to have you and, hopefully, you'll offer us some of your expertise here. In general, I did want to give
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot